Werewolf Therapeutics (HOWL) Shares Outstanding (Entity) (2020 - 2026)
Powered by 
Analysis
Werewolf Therapeutics (HOWL) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 207.01 Bn | 193.02 Bn | 7.24 Bn | 540.60 Mn |
| 2 | Gilead Sciences | 179.98 Bn | 176.80 Bn | 6.22 Bn | 1.24 Bn |
| 3 | Vertex Pharmaceuticals | 131.45 Bn | 123.60 Bn | 2.84 Bn | 253.35 Mn |
| 4 | Regeneron Pharmaceuticals | 82.02 Bn | 74.03 Bn | 3.93 Bn | 102.80 Mn |
| 5 | Argenx Se | 60.35 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.69 Bn | 48.55 Bn | 52.00 Mn | 399.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.11 Bn | 29.80 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Biogen | 31.93 Bn | 30.64 Bn | 1.96 Bn | 147.75 Mn |
| 9 | Roivant Sciences | 29.21 Bn | 29.21 Bn | 1.16 Mn | 722.67 Mn |
| 10 | Werewolf Therapeutics | 47.70 Mn | 47.70 Mn | - | 48.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 48.60 Mn |
| Mar 31, 2026 | 48.60 Mn |
| Dec 31, 2025 | 48.60 Mn |
| Sep 30, 2025 | 47.27 Mn |
| Jun 30, 2025 | 45.34 Mn |
| Mar 31, 2025 | 44.83 Mn |
| Dec 31, 2024 | 44.83 Mn |
| Sep 30, 2024 | 43.72 Mn |
| Jun 30, 2024 | 43.70 Mn |
| Mar 31, 2024 | 43.28 Mn |
| Dec 31, 2023 | 39.11 Mn |
| Sep 30, 2023 | 35.66 Mn |
| Jun 30, 2023 | 35.64 Mn |
| Mar 31, 2023 | 35.30 Mn |
| Dec 31, 2022 | 31.43 Mn |
| Sep 30, 2022 | 30.61 Mn |
| Jun 30, 2022 | 28.28 Mn |
| Mar 31, 2022 | 27.42 Mn |
| Dec 31, 2021 | 18.46 Mn |
| Sep 30, 2021 | 27.22 Mn |